Sex disparities in cystic fibrosis in the era of highly effective modulator treatment.
Issue Date
2025-05-02Keywords
cystic fibrosisDisparity
Hormone
Modulator
SEX
Metadata
Show full item recordJournal
BMC pulmonary medicineDOI
10.1186/s12890-025-03621-0PubMed ID
40316939Item Type
ArticleOther
Language
enEISSN
1471-2466ae974a485f413a2113503eed53cd6c53
10.1186/s12890-025-03621-0
Scopus Count
Collections
The following license files are associated with this item:
- Creative Commons
Related articles
- Modulator-refractory cystic fibrosis: Defining the scope and challenges of an emerging at-risk population.
- Authors: Somerville L, Borish L, Noth I, Albon D
- Issue date: 2024 Jan-Dec
- Sex Differences After Treatment With Ivacaftor in People With Cystic Fibrosis.
- Authors: Holtrop M, Cosmich S, Lee M, Keller A, Jain R
- Issue date: 2024 Nov
- Racial disparities in lung transplantation for cystic fibrosis in the era of highly effective modulator therapy.
- Authors: Ruck JM, Feng SN, Toporek AH, Shah PD, Tallarico E, Lechtzin N, Massie AB, Segev DL, Bush EL, Merlo CA
- Issue date: 2025 Mar
- Increasing incidence rate of breast cancer in cystic fibrosis - relationship between pathogenesis, oncogenesis and prediction of the treatment effect in the context of worse clinical outcome and prognosis of cystic fibrosis due to estrogens.
- Authors: Stastna N, Brat K, Homola L, Os A, Brancikova D
- Issue date: 2023 Mar 20
- Cystic Fibrosis: Highly Effective Targeted Therapeutics and the Impact on Sex and Racial Disparities.
- Authors: Montemayor K, Jain R
- Issue date: 2022 Nov